CERVICAL RIPENING BALLOON AS A METHOD OF PREINDUCTION--ONE CENTER STUDY.
Induction of labor before its spontaneous onset is often necessary in everyday practice. If the indications for labor induction are satisfied, it is not recommended to wait for spontaneous contractions in the best interest of mother and child (1,2). The most common indications for preinduction are gestational diabetes (GDM), oligohydramnios, intrauterine growth restriction (IUGR), pregnancies after 41 weeks of pregnancy and avoidance of unfavorable circumstances such as delivery in the night hours or lack of experienced staff (2,3). Also, some specific obstetric conditions such as preeclampsia, pregnancy induced or aggravated hypertension, oligohydramnios and cholestasis are reasons for labor induction (1).
The oldest methods of labor preinduction are mechanical devices. Nowadays, these are replaced by pharmacological agents. However, pharmacological agents have side effects, e.g., tachysystole. They also have specific storage requirements, expiration time and higher price (4,5).
On the other hand, mechanical devices for labor induction are unpleasant, have a higher risk of maternal and neonate infection, as well as the risk of hemorrhage and need for oxytocin. When compared to pharmacological agents, time before onset of contractions is longer. There is no difference in cesarean section (CS) incidence (4,5).
The aim of our study was to evaluate the effect of using cervical ripening balloon (CRB) in preinduction on the mode of delivery.
Materials and Methods
We present a longitudinal, cohort, intervention, non-randomized one center study. All women included in the study had the criteria for medical induction and Bishop score under 6. Inclusion criteria were term pregnancies with GDM, oligohydramnios, IUGR, gestational hypertension/preeclampsia, and pregnancies after 41 weeks of pregnancy. We established duration of pregnancy by ultrasound examination in first trimester. Preinduction of labor was performed in term pregnancies at Sestre milosrdnice University Hospital Center.
The Cook Medical[R] CRB (Bloomington, USA) has been used for labor preinduction at our department. It is a double-balloon catheter guided by stylet during placement. Internal balloon is placed through the cervix in the uterine cavity and filled with 20 mL of saline, and the external one is outside the cervix, also filled with 20 mL of saline. The balloons are later enlarged by adding 20 mL of saline to up to 80 mL maximum each. After placement of the catheter, there is no need for rest in bed, as is the case in prostaglandin induced labor. The balloon catheter is removed after 12 hours.
We present our experience in 150 patients with cervical balloon preinduction. We analyzed characteristics of the study population according to the mode of delivery and indications for CS, association between the number of comorbidities and presence of dystocia and asphyxia, and difference in birth weight and labor duration between patients with dystocia and asphyxia. Besides objective parameters, we questioned pregnant women about their subjective opinion about this preinduction method.
Patient characteristics were assessed using descriptive statistics, expressed as mean with standard deviation. Continuous variables were compared with oneway analysis of variance (one-way ANOVA) or Kruskal-Wallis test when appropriate. Categorical variables were analyzed using the [chi square]-test. Logistic regression was used to analyze the link between patient characteristics and the incidence of CS. Backward conditional stepwise approach was used to determine variables independently associated with CS. Regression equation was constructed based on the parameters that were independently associated with CS based on unstandardized correlation coefficients derived from the final step of stepwise conditional backward logistic regression. Receiver operating characteristic (ROC) analysis was performed to determine the sensitivity, specificity, positive and negative likelihood ratio of the regression equation in predicting CS. Two-sided p values <0.05 were considered significant. Statistical analysis was done using SPSS Version 20.0.
The study included 150 patients; one patient was excluded from further analyses due to conversion of fetal presentation (head to breech). Indications for labor preinduction were as follows: term pregnancies with GDM, oligohydramnios, IUGR, gestational hypertension/preeclampsia and pregnancies after 41 weeks of pregnancy. Characteristics of the study population are shown in Table 1. Patients with normal vaginal delivery (96/149) had lower rates of GDM and oligohydramnios and used epidural analgesia more frequently. CS was performed in 53 patients. Patients with dystocia (32/53) had a significantly longer labor duration and higher neonatal birth weight (Table 1). The number of major comorbidities was significantly higher in patients with dystocia (Fig. 1).
On multivariate analysis, multiparity, greater cervical dilatation after balloon removal and the use of epidural analgesia were associated with a decreased risk of CS, whereas the presence of GDM and oligohydramnios was associated with an increased risk of CS (Table 2).
The following regression equation was constructed: multiparity x 2.642 - dilatation after CRB x 0.338 - epidural analgesia x 1.588 + GDM x 0.984 + oligohydramnios x 1.073. The equation had 79% diagnostic accuracy in predicting CS (AUC 0.787, SE 0.039, 95% CI 0.712 - 0.863). A cut-off >-1.1025 best predicted CS with 71.7% sensitivity and 75.8% specificity (Fig. 2).
On multivariate analysis of women who gave birth by CS, asphyxia was associated with shorter labor duration (OR 0.504, 95% CI 0.311-0.817, p=0.005), greater neonatal birth weight (OR 0.994, 95% CI 0.990-0.998, p=0.004) and absence of GDM (OR 0.065, 95% CI 0.006-0.671, p=0.022), when compared with dystocia. Difference in neonatal birth weight and labor duration between the two groups is presented in Figure 3.
Out of 150 women, 138 were satisfied with this preinduction method and stated to have a peaceful night without pain. Another 12 women experienced minor discomfort and light pressure in lower abdomen. None of the study women had major objections. None of 150 women and their newborns had infection.
Safety of the mother and the newborn should always come first, knowing the side effects of pharmacological agents used for labor induction (4,6). When CRB is used, mechanical dilatation of the cervix is achieved by gradual increase of the pressure in the balloons. Cervical ripening is achieved by local production of prostaglandins induced by division of the amnion from the decidua, as well as by mechanical dilatation of the cervix (7,8).
Randomized studies mostly report the same efficiency of labor preinduction with CRB and prostaglandin E2 (9,10). Brown and Beckmann found a higher number of vaginal deliveries, less fetal acidosis, less blood loss, and more subjective satisfaction in the CRB group compared with prostaglandin E2 group (9). Lim et al. recorded the same level of subjective satisfaction in both groups but the intensity of pain was lower in the CRB group (10).
Even more interesting are studies of CRB labor preinduction in women with previous CS (11,12), concluding that this preinduction method is safe and effective (11). Over 50% of pregnant women had successful vaginal delivery. The rate of intrapartal CS scar rupture was 1.2% and did not differ from the group with CS scar (11). Radan et al. report the same safety of CRB and oxytocin but found significantly less successful vaginal deliveries in CRB group women with CS scar. The groups were not comparable due to inclusion of different Bishop scores at the beginning of the study (13). Sharma et al. conducted a randomized study comparing oral administration of prostaglandin E1 and CRB in women with prior CS (14). They also found significantly less successful induction in CRB group and higher need for oxytocin. There was no difference in the mode of delivery between the groups (14).
In our study, we put more accent on group characteristics than on method efficiency, since these data are already widely available in the literature. We analyzed the course and mode of delivery in cases with medical indications for labor induction in pregnant women with immature cervix (Bishop score under 6) (15). Prostaglandins may be risky in these cases and most of the women would be candidates for elective CS without CRB labor preinduction. However, two-thirds of the women in our study had successful vaginal delivery. In the group that had CS, dystocia was indication for CS in 32/149 and asphyxia in 21/149 women. Specific risk factors for CS are labor duration and weight of the newborn. The risks connected with dystocia are prolonged labor duration and higher weight of the newborn.
Advantages of this technique include lower cost compared with some drugs, low risk of tachysystole, few systemic side effects, and convenient storage requirements (no refrigeration or expiration, which are issues for some drugs) (4,5,16).
In conclusion, we found this preinduction method safe, efficient, and offering potential to increase the rate of vaginal deliveries in pregnant women with medical indication for induction.
(1.) Rozenberg P. In case of fetal macrosomia, the best strategy is the induction of labor at 38 weeks of gestation. J Gynecol Obstet Biol Reprod (Paris). 2016. pii: S0368-2315(16)30102-8. (In French) http://dx.doi.org/10.1016/j.jgyn.2016.09.001.
(2.) Boulvain M, Irion O, Dowswell T, Thornton JG. Induction of labour at or near term for suspected fetal macrosomia. Cochrane Database Syst Rev. 2016;(5):CD000938. http://dx.doi.org/10.1002/14651858.CD000938.pub2
(3.) Rydahl E, Eriksen L, Juhl M. Effects of induction of labor prior to post-term in low-risk pregnancies: a systematic review. JBI Database System Rev Implement Rep. 2018 Oct 5. http://dx.doi.org/10.11124/JBISRIR-2017-003587. [Epub ahead of print]
(4.) Du YM, Zhu LY, Cui LN, Jin BH, Ou JL. Double-balloon catheter versus prostaglandin E2 for cervical ripening and labour induction: a systematic review and meta-analysis of randomised controlled trials. BJOG. 2016 Aug 17. [Epub ahead of print]. http://dx.doi.org/10.1111/1471-0528.14256
(5.) Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Medley N, Dias S. Methods to induce labour: a systematic review, network meta-analysis and cost-effectiveness analysis. BJOG. 2016;123 (9):1462-70. http://dx.doi.org/10.1111/1471-0528.13981
(6.) Vogel J, Osoti AO, Kelly AJ, Livio S, Norman JE, Alfirevic Z. Pharmacological and mechanical interventions for labour induction in outpatient settings. Cochrane Database Syst Rev. 2017;9:CD007701. http://dx.doi.org/10.1002/14651858.CD007701.pub3
(7.) Teo EY, Kumar S. Intrapartum intervention rates and perinatal outcomes following induction of labour after 41+0 weeks compared to expectant management. J Matern Fetal Neonatal Med. 2017;30(21):2517-20. http://dx.doi.org/10.1080/14767058.2016.1255190
(8.) Menon R. Human fetal membranes at term: dead tissue or signalers of parturition? Placenta. 2016;44:1-5. http://dx.doi.org/10.1016/j.placenta.2016.05.013
(9.) Brown J, Beckmann M. Induction of labour using balloon catheter and prostaglandin gel. Aust N Z J Obstet Gynaecol. 2017;57(1):68-73. http://dx.doi.org/10.1111/ajo.12577
(10.) Lim SE, Tan TL, Ng GYH, Tagore S, Kyaw EEP, Yeo GSH. Patient satisfaction with the cervical ripening balloon as a method for induction of labour: a randomised controlled trial. Singapore Med J. 2018;59(8):419-24. http://dx.doi.org/10.11622/smedj.2018097
(11.) De Bonrostro Torralba C, Tejero Cabrejas EL, Marti Gamboa S, Lapresta Moros M, Campillos Maza JM, Castan Mateo S. Double-balloon catheter for induction of labour in women with a previous cesarean section, could it be the best choice? Arch Gynecol Obstet 2017;2955:1135-43. http://dx.doi.org/10.1007/s00404-017-4343-7
(12.) Kehl S, Weiss C, Rath W. Balloon catheters for induction of labor at term after previous cesarean section: a systematic review. Eur J Obstet Gynecol Reprod Biol 2016;204:44-50. http://dx.doi.org/10.1016/j.ejogrb.2016.07.505
(13.) Radan AP, Amylidi-Mohr S, Mosimann B, Simillion C, Raio L, Mueller M, Surbek D. Safety and effectiveness of labour induction after caesarean section using balloon catheter or oxytocin. Swiss Med Wkly. 2017;147:w14532. http://dx.doi.org/10.4414/smw.2017.14532. eCollection 2017
(14.) Sharma C, Soni A, Gupta A, Verma A, Verma S. Mifepristone vs balloon catheter for labor induction in previous cesarean: a randomized controlled trial. Arch Gynecol Obstet. 2017; 296(2):241-8. http://dx.doi.org/10.1007/s00404-017-4431-8
(15.) Ezebialu IU, Eke AC, Eleje GU, Nwachukwu CE. Methods for assessing pre-induction cervical ripening. Cochrane Database Syst Rev. 2015 Jun 12;(6):CD010762. http://dx.doi.org/10.1002/14651858.CD010762.pub2
(16.) Durie D, Lawal A, Zegelbone P. Other mechanical methods for pre-induction cervical ripening. Semin Perinatol. 2015;396:444-9. http://dx.doi.org/10.1053/j.semperi.2015.07.006
BALON ZA SAZRIJEVANJE CERVIKSA MATERNICE U PREDINDUKCIJI PORODAJA--JEDNOCENTRICNA STUDIJA
V. Kosec, I. Djakovic i S. Sabolovic Rudman
Sazrijevanje cerviksa maternice moze se poticati na nekoliko nacina. Najstarije metode su mehanicke metode koje imaju svojih prednosti i nedostataka. Nedostaci u usporedbi s farmakoloskim metodama ukljucuju odredenu majcinsku nelagodu pri manipulaciji cerviksom maternice, povecanje rizika od majcine i neonatalne infekcije zbog unosenja stranog tijela, mogucnost ozljede posteljice niskog sijela i povecanu potrebu za uporabom oksitocina u porodaju. Cilj istrazivanja bio je procijeniti ucinak koristenja balona na sazrijevanje cerviksa maternice u predindukciji porodaja. Provedena je longitudinalna, kohortna, intervencijska, ne-randomizirana studija. Kriteriji za ukljucivanje bili su terminske trudnoce s gestacijskim dijabetesom, oligohidramnijem, intrauterinim zastojem u fetalnom rastu, gestacijskom hipertenzijom/preeklampsijom i trudnoca nakon navrsenih 41 tjedna trudnoce. Studiju smo provodili kod zena s terminskim trudnocama u Klinickom bolnickom centru Sestara milosrdnica. Prikazani su rezultati u prvih 150 trudnica kod kojih je provedena predindukcija porodaja cervikalnim balonom. Vrijednosti p<0,05 smatrale su se znacajnima. Statisticka analiza provedena je pomocu SPSS Version 20.0. Studija je obuhvatila 150 trudnica, a jedna zena je bila iskljucena iz daljnjih analiza zbog konverzije fetalnog stava (glave u zadak). Indikacije za predindukciju porodaja su bile: gestacijski dijabetes, oligohidramnij, intrauterini zastoj fetalnog rasta, gestacijska hipertenzija/preeklampsija i trudnoca nakon navrsenih 41 tjedna trudnoce. Trudnice koje su rodile vaginalno (96/149) imale su manju ucestalost gestacijskog dijabetesa i oligohidramnija i kod njih je cesce koristena epiduralna analgezija. Trudnice bez napredovanja porodaja (32/53) imale su znacajno duze trajanje porodaja i vecu tjelesnu tezinu novorodenceta. U multivarijatnoj analizi su multiparitet, veca dilatacija cerviksa nakon uklanjanja balona i primjena epiduralne analgezije bili povezani sa smanjenim rizikom carskog reza, dok je prisutnost gestacijskog dijabetesa i oligohidramnija bila povezana s povecanim rizikom carskog reza. Smatramo da je ova predindukcijska metoda sigurna, ucinkovita i moze dovesti do povecanja broja vaginalnih porodaja.
Kljucne rijeci: Porodaj; Porodaj, inducirani; Cerviks, sazrijevanje; Cerviks uterusa; Carski rez
Vesna Kosec, Ivka Djakovic and Senka Sabolovic Rudman
Department of Gynecology and Obstetrics, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Correspondence to: Ivka Djakovic, MD, Department of Gynecology and Obstetrics, Sestre milosrdnice University Hospital Center, Vinogradska c. 29, HR-10000 Zagreb, Croatia
Received October 17, 2018, accepted December 7, 2018
Table 1. Characteristics of study population according to the mode of delivery and indication for cesarean section Vaginal (A) CS N=96 Dystocia (B) N=32 Age (years) 30.9 [+ or -]4.7 30.7 Multiparity, 13 (13.5) 1 n (%) Indications: GDM, n (%) 44 (45.3) 12 Oligohydramnios, 15 (15.8) 10 n (%) IUGR, n (%) 12 (12.6) 1 Preeclampsia/hypertension, 12 (12.6) 7 n (%) Pregnancies after 41 weeks, 13 (13.7) 2 n (%) Labor duration (hours) 6.8 [+ or -]3.0C 8.4 Oxytocin use, n (%) 92 (95.8) 30 Cervical dilatation after 3.6 [+ or -]1.3 3.0 balloon removal (cm) Neonatal weight (g) 3342 [+ or -]469 3589 Male gender, n (%) 40 (41.7) 18 Gestation age (weeks) 40.3 [+ or -]1.1 40.2 Epidural anesthesia, 53 (55.2) 9 n (%) Fetal position anomaly, 3 (3.1) 1 n (%) CS CS Dystocia (B) Asphyxia (C) N=32 N=21 Age (years) [+ or -]5.6 30.2 [+ or -]5.3 Multiparity, (3.1) 0 (0) n (%) Indications: GDM, n (%) (39.4) 6 (28.6) Oligohydramnios, (30.3) 5 (23.8) n (%) IUGR, n (%) (3.0) 3 (14.3) Preeclampsia/hypertension, (21.2) 4 (19.0) n (%) Pregnancies after 41 weeks, (6.1) 3 (14.3) n (%) Labor duration (hours) [+ or -]2.8AC 5.0 [+ or -]2.8 Oxytocin use, n (%) (93.8) 19 (90.5) Cervical dilatation after [+ or -]1.2A 3.0 [+ or -]1.2A balloon removal (cm) Neonatal weight (g) [+ or -]390AC 3118 [+ or -]330 Male gender, n (%) (56.2) 10 (47.6) Gestation age (weeks) [+ or -]0.9 40.3 [+ or -]1.2 Epidural anesthesia, (28.1)A 7 (33.3) n (%) Fetal position anomaly, (3.2) 0 (0) n (%) P Age (years) 0.857 Multiparity, 0.061 n (%) Indications: GDM, n (%) Oligohydramnios, n (%) IUGR, n (%) Preeclampsia/hypertension, n (%) Pregnancies after 41 weeks, n (%) Labor duration (hours) <0.001 Oxytocin use, n (%) 0.596 Cervical dilatation after 0.032 balloon removal (cm) Neonatal weight (g) 0.001 Male gender, n (%) 0.351 Gestation age (weeks) 0.777 Epidural anesthesia, 0.013 n (%) Fetal position anomaly, 0.255 n (%) CS = cesarean section; A = p<0.05 when compared to vaginal delivery group; B = p<0.05 when compared to dystocia cesarean section group; C = p<0.05 when compared to asphyxia cesarean section group; GDM = gestational diabetes; IUGR = intrauterine growth restriction; fetal position anomaly = left occiput or right occiput Table 2. Final step of backward conditional stepwise logistic regression showing independent variables associated with the risk of cesarean section B SE HR 95% CI p Multiparity -2.642 1.113 0.071 0.008 0.631 0.018 Dilatation -.338 0.170 0.713 0.510 0.996 0.047 after CRB Epidural -1.588 0.417 0.204 0.090 0.462 0.000 anesthesia GDM 0.984 0.414 2.674 1.189 6.017 0.017 Oligohydramnios 1.073 0.457 2.924 1.194 7.161 0.019 B = unstandardized correlation coefficient; SE = standard error; HR = hazard ratio; CRB = cervical ripening balloon; GDM = gestational diabetes mellitus
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Professional Paper|
|Author:||Kosec, Vesna; Djakovic, Ivka; Rudman, Senka Sabolovic|
|Publication:||Acta Clinica Croatica|
|Article Type:||Clinical report|
|Date:||Dec 1, 2018|
|Previous Article:||THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA.|
|Next Article:||ISCHEMIC PITUITARY APOPLEXY, HYPOPITUITARISM AND DIABETES INSIPIDUS: A TRIAD UNIQUE TO NECROTIZING HYPOPHYSITIS.|